The impact of particle size of aerosolized polymeric diphenylmethane-4,4-diisocyanate (MDI) for the induction and elicitation of respiratory sensitization was evaluated. Four groups of 16 female guinea pigs each received either the vehicle, repeated intradermal (id) injections (3 ؋ 0.3% MDI), one high-level inhalation exposure of 15 min to 135 mg MDI/m 3 air using a small aerosol (MMAD Ϸ 1.7 m) or large aerosol (MMAD Ϸ 3.8 m). Three weeks later, animals were challenged subsequently with two ramped concentrations of MDI aerosol (average concentrations 16 and 49 mg/m 3 air, each for 15 min) and two different particle sizes, i.e., the MMAD was either Ϸ 1.6 m or Ϸ 5.1 m for the smalland large-size aerosol, respectively. Respiratory sensitization was assessed by two endpoints: the measurement of respiratory rate, and examination of influx of eosinophilic granulocytes into the mucosa and submucosa of the trachea, bronchi, and lung-associated lymph nodes (LALN). The recruitment of eosinophilic granulocytes into bronchial tissues was subdivided as follows: muscularis mucosae, submucosa, and perivascular. From measurements of respiratory rate, it would appear that guinea pigs sensitized by id injections or by inhalation exposure with the large aerosol tended to display a higher responsiveness than naive controls when challenged with the small aerosol. The recruitment of eosinophilic granulocytes in the bronchial tissue was greater in both inhalation induction groups as compared to the vehicle control. It appears that there was a somewhat greater response in animals sensitized by id injections or by inhalation exposure with the large aerosol and challenged with the small aerosol. Topographically, this difference was apparent only at the bronchial perivascular level and lung-associated lymph nodes (LALN), whereas at the submucosal and muscularis mucosae level the impact on particle size tended to be less pronounced. In summary, this study suggests that a brief, high-level inhalation exposure of MDI aerosol caused a sensitization of bronchial tissues in guinea pigs. The higher sensitization potency of the large aerosol may possibly be related to a dosimetric phenomenon because of the greater fraction of deposition of large particles within the upper respiratory tract. Overall, challenge exposures with this type of irritant aerosol appear to evoke more consistent effects when the MMAD is in the range of Ϸ 2 rather than Ϸ 5 m.
Guinea pigs have been widely used to investigate allergenprovoked changes in pulmonary function and inflammatory cell influx because of the similarities that exist with the human asthmatic response, the mediators involved, and the reactivity of the airways to bronchoactive agents. Details of the advantages and disadvantages of this animal model for the identification of low molecular weight asthmogens have been reviewed elsewhere (e.g., Briatico-Vangosa et al., 1994; Karol, 1994; Sugawara et al., 1993) .
Despite the guinea pigs' sensitivity for the identification of the allergenic potential of proteins, in many instances sensitized guinea pigs did not fully display surrogate immediate onset type asthmatic responses from challenge with diphenylmethane-4,4Ј-diisocyanate (MDI), but did when challenged with the low molecular weight chemical trimellitic anhydride (TMA) (Pauluhn et al., 1999a) . Though difficult to reconcile, one source of potential variability appears to be related to the particle size of MDI aerosol used for inhalation induction and elicitation of sensitization responses. To clarify as to whether particle size is an important variable in this bioassay, the impact of MDI aerosol particle size on the outcome on both the induction and elicitation of sensitization response was examined. Attempts were made to induce and challenge guinea pigs to two-size distributions of MDI aerosol. One was preferentially deposited in the lower airways in the absence of appreciable deposition in the nasopharyngeal airways (small aerosol: targeted MMAD Ϸ 1.5 m), whereas the large aerosol was targeted to be deposited preferentially in the extrathoracic, nasopharyngeal airways (large aerosol: targeted MMAD Ϸ 5 m). Though it can be assumed that the total deposition of the large aerosol exceeds that of the small one by a factor of approximately 2 (Martonen and Yang, 1994) , no attempt was made to exactly qualify the most likely regional deposition because of the polydisperse nature of the aerosol generated.
Guinea pigs sensitized by inhalation to either small or large aerosol were compared with both naive animals and those sensitized by an extrapulmonary (intradermal) route. To minimize the occurrence of potential confounding factors upon challenge due to pre-existing, induction-related airway inflammation, inhalation sensitization was made using a brief, highlevel exposure of 135 mg/m 3 polymeric MDI without any additional booster inhalation exposures.
Two endpoints were examined to characterize positive response. One focused on the identification of immediate-onset response by measurements of respiratory rate during challenge exposure; the other focused on the identification of an influx of eosinophils in bronchial airways and lung-associated lymph nodes. This allowed the identification of a late-phase inflammatory response. In this context, increasing evidence suggests that eosinophilic granulocytes play a critical role in the pathogenesis of asthma and of other hyperresponsive airway diseases and differentiates asthma from other inflammatory conditions of the airways (Barnes et al., 1991a,b; Davis et al., 1984; Frigas and Gleich, 1986; Kay et al., 1991; Lapa e Silva et al., 1993 , 1997 Obata et al., 1992) . No attempts were made to demonstrate an associated late-phase bronchoconstriction by measurements of respiratory function because they were often described to be unsuccessful (Pauluhn and Eben, 1991; Pauluhn, 1997; Richards et al., 1992) .
MATERIALS AND METHODS
Test materials. The polymeric diphenylmethane-4,4Ј-diisocyanate used in this study (MDI) was a brownish, translucent viscous liquid containing Ϸ 50% monomeric 4,4Ј-MDI, Ϸ 4% monomeric 2,4Ј-MDI, Ϸ 34% 3-oligomeric MDI, Ϸ 9% 4-oligomeric MDI (balance: higher isomeric homologs). One trade name of such a mixture is DESMODUR 44 V 20 L (DESMODUR is a trade name of Bayer AG, Leverkusen, Germany). MDI of other producers differs only slightly in chemical composition and physicochemical properties. The NCO content of the test specimen was 31.5% (w/v). MDI was stored under an inert gas (dry nitrogen) until use. The monomeric MDI used in the pilot study was also from Bayer AG (purity Ͼ 99%).
Animals, diet, and housing conditions. Female Dunkin-Hartley guinea pigs (Crl:[HA]BR) with an initial weight range of 300 -350 g were obtained from Charles River, Sulzfeld, Germany. Animals were acclimatized for approximately 1 week, randomized, and housed four per cage. Guinea pigs were allowed food and tap water ad libitum except during exposures. A 12-h on/off light cycle was maintained in the animal housing room. Temperature was 23 Ϯ 2°C and relative humidity was in the range of 40 -70%. All experiments and procedures described were performed in compliance with GLP requirements (OECD, 1983) , taking into account the EU animal welfare regulations (EC Directive 86/609/EC, 1986).
Sensitization to and challenge with MDI. All inhalation exposures were nose-only, as described in the section on inhalation exposure techniques.
Intradermal sensitization. One group of guinea pigs (n ϭ 16) received a single id injection on days 0, 2, and 4 (injection volume 100 l, 0.3% MDI [w/v]) MDI in dehydrated corn oil as vehicle. The relative locations on the flanks used for repeated injection were cranial, thoracic, and caudal. Control animals (n ϭ 16) received vehicle alone under otherwise identical conditions. Prior to each injection, the MDI content of the solution was verified analytically.
Inhalation sensitization. Two groups of guinea pigs, each of 16 animals, were sensitized with 135 mg/m 3 of respirable MDI aerosol (actual gravimetric concentration) by a single 15-min nose-only inhalation exposure. The aerosol atmospheres generated in the first and second group differed in particle size. In the first group, guinea pigs were exposed to a small aerosol and in the second group to a large aerosol. The small and large aerosol were targeted at MMADs of Ϸ 1.5 and Ϸ 5 m, respectively.
Challenge

MDI.
After a postexposure period of approximately 3 weeks (range: days 19 -23), guinea pigs were challenged with MDI aerosol using a ramped exposure regimen (target concentrations 15 and 45 mg/m 3 air; each challenge duration was 15 min, subsequent exposure). For the first and second challenge periods, the mean actual concentrations (Ϯ standard deviation) obtained by filter analyses were 16.0 Ϯ 2.2 and 49.4 Ϯ 12.7 mg MDI/m 3 air, respectively. Half of the animals in each group were challenged with a small aerosol; the other half of the animals were challenged with a large-size aerosol.
Exposure technique, aerosol generation, and characterization. Atmospheres of MDI were generated under dynamic conditions using a digitally controlled Hamilton Microlab M pump and a modified Schlick-nozzle Type 970, form-S 3 (Schlick GmbH, Coburg, Germany). Temperature control of the nozzle was made by a water jacket connected to a digitally controlled thermostat. MDI was nebulized using conditioned (dry, oil-free) compressed air. The aerosol for induction (I) and challenge (C) exposures was generated as follows: (I) the liquid polymeric MDI was nebulized using compressed, conditioned (dry, oil-free) air. The small aerosol of MDI was generated by nebulization of 25 l ϫ min -1 and a dispersion pressure of approximately 600 kPa. All parts of the nozzle coming into contact with MDI were maintained at approximately 40°C using a water jacket connected to a digitally controlled thermostat. The large aerosol was generated under similar conditions but using 150 kPa dispersion pressure and a nozzle temperature of 25°C. (C) The aerosol was generated as described above using the following modifications: the small aerosol of MDI was generated by nebulization of 10 l ϫ min -1 , a dispersion pressure of approximately 600 kPa, and a temperature of approximately 40°C. The large aerosol was generated under similar conditions but using a dispersion pressure of 100 kPa, a supply rate of 50 l MDI ϫ min -1 , and a nozzle temperature of 25°C. The total airflow to the nose-only inhalation chamber (internal volume of chamber Ϸ 7.2 L) was 30 L ϫ min -1 . The increase of temperature within the nozzle resulted in a marked decrease in viscosity and hence increased reproducibly the output of aerosol of polymeric MDI. The respective target concentration was attained by using an extraction/dilution cascade as depicted in Figure 1 . With respect to the generation of this aerosol as well as to this modular directed-flow nose-only inhalation chamber have been described elsewhere (Pauluhn, 1994b; Pauluhn et al., 1999b) . The generation of the monomeric aerosol used in the pilot study has been published previously (Pauluhn et al., 1999a) . The exposure atmospheres were characterized using filter analyses (Sartorius glass fiber filters). Chamber air was sampled from the vicinity of the breathing zone of the guinea pigs. For particle size analyses, a low-pressure critical orifice AERAS stainless steel cascade impactor (HAUKE, 4810 Gmunden, Austria) was used. The mass median aerodynamic diameter (MMAD) and the geometric standard deviation (GSD) were calculated as described previously (Pauluhn, 1994b) .
Measurement and analysis of immediate-onset pulmonary responses.
Challenge-induced changes in respiratory rate, including tidal volume (no data reported), were measured and analyzed as described previously (Pauluhn, 1997) . Briefly, after acclimatization to the nose-only plethysmograph, the baseline respiratory rate was measured for approximately 15 min. Measurements were continued during the 2 ϫ 15-min challenge periods, followed by postchallenge measurements of approximately 30 min. Measurements were made with eight guinea pigs simultaneously. Signals were averaged during logging periods of 20 s. Data collection and evaluation were made using a commercially available system (PO-NE-MAH Digital Acquisition, Analysis & Archive System, Simsbury, CT, USA, equipped with PLUGSYS amplifiers, H. Sachs, March, Germany). The analysis of data was as follows: for each animal, the individual baseline data collected during the 15 min prechallenge period was used to calculate the baseline mean ϩ 3 ϫ standard deviation (SD). All data collected were normalized to the mean of this prechallenge period (ϭ 100%), and the area under the curve exceeding the mean ϩ 3 SD was calculated. For this particular study, increased responsiveness was defined by a respiratory rate intensity (area) exceeding 50, because only a few control animals exceeded this threshold value. This threshold value differs from previous measurements (Pauluhn, 1997) due to the modification of the challenge protocol, agent used for challenge exposures, and a shorter duration of the postchallenge period.
Necropsy and histopathology.
In all groups, animals were sacrificed 1 day after challenge, and the nasal cavities, lung, trachea, and lung-associated lymph nodes (LALN) were preserved for histopathological examinations. Following complete exsanguination, lungs were weighed and fixed by instillation. The fixation of tissue was in 4% neutral buffered formaldehyde. All tissues were routinely processed, dehydrated, and embedded in Paraplast-plus, and sections approximately 5 m thick were cut from each tissue block. Tissue sections were stained with hematoxylin and eosin according to Lillie & Mayer (Lillie and Fullmer, 1976) hematoxylin-eosin-azure (Tan and Bethel, 1992) to improve the identification of eosinophilic granulocytes. All examinations were made by light microscopy. For grading, the number of eosinophilic granulocytes in a rectangular unit area of 0.1722 mm 2 (0.82 ϫ 0.21 mm) was counted and graded as follows: grade 0, no eosinophils; grade 1 (slight), up to 30 eosinophils/unit area; grade 2 (moderate), 31-80 eosinophils/unit area; grade 3 (severe), more than 81 eosinophils/unit area. Three distinct locations were examined: the perivascular, the submucosal, and the muscularis mucosae areas. These areas were examined and scored independently in the five lung lobes, i.e., lobus dexter accessorius, lobus sinister caudalis, lobus sinister cranialis, lobus dexter mediatus, and lobus dexter caudalis. The examination of influx of eosinophilic granulocytes at these topographical locations was made because they were also described for the occurrence of dendritic cell (DC) in the guinea pig airways (Lapa e Silva et al., 1993; Lawrence et al., 1997; Maarten et al., 1994) . Lawrence et al. (1997) have observed a large influx of eosinophils into the epithelium of the trachea and bronchi 18 h after antigen challenge as a characteristic late-phase inflammatory response in guinea pigs. Therefore, animals were sacrificed 1 day after the inhalation challenge exposure.
Enzyme-linked immunosorbent assay (ELISA).
For serological analyses, blood was drawn from guinea pigs by cardiac puncture approximately 3 weeks following inhalation exposure or initiation of id injection. Serum was prepared and stored at -20°C until analyzed. Plastic microtiter plates (Nunc Immunoplate type II, Nunc, Copenhagen, Denmark) were coated with 50 l per well of 5 g/ml MDI-guinea pig serum albumin conjugate (MDI-GPSA) in 0.5 M sodium carbonate/bicarbonate buffer (pH 9.6) by overnight incubation at 4°C. Various dilutions of guinea pig serum in phosphate-buffered saline containing 0.05% Tween 20 (PBS-Tween) were added in duplicate (100-l aliquots) and plates were incubated for 30 min at 37°C. Plates were washed three times in PBS-Tween and 100 l of rabbit anti-guinea pig IgG 1 antibody (Miles Scientific, Slough, UK), diluted 1:2500 in PBS-Tween, was added to each well. Plates were again incubated for 30 min at 37°C and washed prior to addition of a peroxidase-labeled goat anti-rabbit IgG antibody (Miles Scientific), diluted 1:5000 in PBS-Tween. Following a further 30-min incubation at 37°C, the plates were washed again and substrate (o-phenylenediamine and urea hydrogen peroxide) was added. Reactions were terminated after approximately 10 min by addition of 50 l 0.5M citric acid per well. Absorbance was measured at 450 nm using an automatic reader (Multiskan, Flow Laboratories, Irvine, Ayrshire, UK). Criterion for positivity of individual serum samples was as follows: mean optical density for the reagent blank wells was calculated for each plate, as were the means of each duplicate serum sample. A reading was regarded as positive if it was higher than twice the reagent blank for the particular plate. The titer of each serum was the highest dilution of serum that gave a positive reading.
Preparation and characterization of conjugate for ELISA. MDI-GPSA was prepared as described previously (Rattray et al, 1994) . Briefly, approximately 200 mg GPSA was dissolved in 20 ml 0.05 M sodium borate buffer (pH 9.4). Approximately 60 mg monomeric MDI was added and the solution was stirred at 4°C for 30 min. Glass vessels were used throughout, as MDI reacts with plastic. The solution was dialyzed successively against phosphate-buffered saline (pH 7.2) and distilled water for a period of approximately 48 h at 4°C. The lyophilized conjugate was stored at -20°C until use. The degree of substitution of the MDI conjugate was assessed using a method based upon the determination of free amino groups by reaction with 2,4,6-trinitrobenzene sulphonic acid (TNBS), as described previously (Rattray et al., 1994) . Briefly, approximately 1 mg MDI-GPSA conjugate and 1 mg GPSA were each dissolved in approximately 1 ml 0.1 M sodium borate buffer (pH 9.3); 25 l of a stock solution of 1.2 M TNBS in 0.1 M sodium borate buffer (pH 9.3) was added to each sample, and the samples were incubated for approximately 20 min at room temperature. The optical density at 420 nm (OD) was measured using a Philips spectrophotometer (PU 8880uv/vis). GPSA had approximately 30 readily available hapten-binding sites per molecule. The degree of substitution was approximately 15:1 moles hapten:moles protein.
Pilot study for the evaluation of anti-MDI antibody formation. In a separate pilot study, groups of guinea pigs (approximately 8 -10 animals/ group) were sensitized with respirable aerosol of polymeric MDI by single high-level inhalation exposure of 15-min duration. Actual concentrations of MDI aerosol ranged from 5 to 835 mg/m 3 air, i.e., from virtually nonirritant to strongly irritant. In this pilot study, the MMAD of polymeric MDI was approximately 1.6 m (range 1.4 -1.9), and the GSD was approximately 1.5. In one additional group (Ϸ 135 mg/m 3 ), 16 guinea pigs were exposed to monomeric MDI aerosol (MMAD Ϸ 1.1 m, GSD 1.4). Exposure concentrations up to a concentration of Ϸ 135 mg/m 3 were tolerated without specific clinical signs, whereas guinea pigs exposed to 835 mg/m 3 experienced a labored breathing pattern and respiratory distress up to the fourth postexposure day. One out of eight guinea pigs succumbed on the first postexposure day. Following id induction, inflammatory skin reactions were observed at the injection sites.
Statistical evaluation of data. Quantitative histopathological data were analyzed by one-way analysis of variance and Tukey-Kramer post hoc test. Data addressing the respiratory response was analyzed by a Mann-Whitney Rank Sum Test (SPSS). Quantal histopathological findings (incidence of airway eosinophilia) were compared with the concurrent control using the pairwise Fisher test with R ϫ C chi-square test (Gad and Weil, 1982) .
RESULTS
Generation of Polymeric Aerosol of MDI
Concentrations of atmospheres were 135 mg/m 3 for induction and 16 or 49 mg/m 3 for challenge exposures. The generation of small and large particle size distributions covering this range of concentrations was technically demanding and was achieved by variations of dispersion pressures, temperaturerelated changes in the viscosity of MDI, different supply rates of liquid MDI into the temperature-equilibrated nozzle, and by using an extraction/dilution cascade prior to conveying the MDI aerosol into the nose-only inhalation chamber. This number of variables made it difficult to exactly meet the targeted aerosol size-distributions of Ϸ 1.5 m and Ϸ 5 m for the small and large aerosol, respectively. For induction exposure the mean MMAD was 1.7 m (GSD 1.6) and 3.8 m (GSD 2.0), and for challenge exposure the mean MMAD was 1.6 m (GSD 1.6) and 5.1 m (GSD 2.2) for the small and large aerosol, respectively. The respective size distributions are illustrated in Figure 2 . Based on the deposition data reported by Raabe et al. (1988) and Martonen and Yang (1994) , the small aerosol appears to favor deposition within the lower respiratory tract, whereas the more polydisperse large aerosol appears to be preferentially deposited in the upper respiratory tract. Likewise, the total deposition percentage is likely to be greater for the large than for the small aerosol.
Anti-MDI Antibody Production
MDI-specific antibody determinations in guinea pigs of the separate pilot study revealed exposure concentration-related elevated antibody titers (Fig. 3) . Experimental evidence obtained from the one group sensitized with monomeric MDI aerosol (135 mg/m 3 ) suggests that monomeric and polymeric MDI aerosol demonstrated an equal potency of MDI-specific antibody formation. Moreover, guinea pigs exposed to 835 mg MDI/m 3 air for 15 min or sensitized by repeated id injections (3 ϫ 0.3%) elaborated similar antibody titers. Despite exposure to an overtly irritant concentration of 835 mg/m 3 air, the mean MDI-specific antibody formation appeared to follow a relation- ship almost proportional to the concentration used for induction. From this pilot study the conclusion was drawn that induction by a single 15-min inhalation exposure to 135 mg/m 3 polymeric MDI appears to be sufficient to evoke specific IgG 1 antibody production in guinea pigs in the absence of undue respiratory distress.
MDI Aerosol Challenge
No deaths, anaphylactic reactions, stereotypic breathing patterns, or specific clinical signs were observed during or following the challenge with small or large size MDI aerosol in two-stepped concentrations. Specific abnormalities were not observed at necropsy nor were there any apparent effects on body weight gains or lung weights (no data shown).
Analysis of Respiratory Rate
For elicitation of specific respiratory hypersensitivity, guinea pigs of all groups were exposed subsequently to gravimetrically determined concentrations of 16 and 49 mg MDI/m 3 air, each concentration for 15 min. The first eight guinea pigs of each group were challenged with the small, the second half with the large aerosol. The results of measurements of respiratory rate made upon challenge with MDI aerosol are summarized in Figure 4 .
During or following the challenge with MDI, some animals experienced a mild, immediate-onset-like respiratory reaction when evaluated on the basis of an increased respiratory rate (area under the curve that exceeds the mean ϩ 3 SD of the prechallenge period; for details see Pauluhn, 1997) . Animals challenged with 49 mg/m 3 small aerosol MDI tended to display a more increased respiratory rate than those challenged with the same concentration and large aerosol. However, statistical comparisons did not reveal any statistically significant differences between the groups. Naive controls experienced greater increase in respiratory rate when challenged with the large aerosol (Fig. 4) . With respect to the single high-level inhalation exposure, it appears that animals sensitized with the large aerosol tended to elaborate the greater respiratory response than those sensitized with the small aerosol. Elicitation of respiratory sensitization responses, in turn, was apparently more consistent when the aerosol was small rather than large. Thus, with respect to challenge, guinea pigs appear to respond somewhat differently when challenged with mildly irritant concentrations of small or large aerosols of MDI. Furthermore, due to the increased responsiveness observed in controls following challenge with the large size aerosol, it appears that changes in breathing patterns may be more likely misconstrued as positive changes in breathing patterns than those following challenge with the small aerosol.
Histopathology
Findings in the nasal cavities and trachea were unremarkable ( Table 1) . As no appreciable or systematic differences of influx of eosinophilic granulocytes in airways of the lobus dexter accessorius, lobus sinister caudalis, lobus sinister cranialis, 
FIG. 3.
Determination of IgG 1 anti-MDI antibody of guinea pigs from a separate pilot study. Antibodies were determined using an ELISA assay on blood collected by cardiac puncture at sacrifice 3 weeks after induction with MDI aerosol. Guinea pigs were sensitized either by single inhalation exposures of 15-min duration or by repeated intradermal (id) injections. Airborne concentrations of MDI ranged from 5 to 835 mg/m 3 air and represent gravimetric analyses. Id 3 ϫ 0.3%: repeated intradermal injections on days 0, 2, and 4 using an injection volume of 100 l (concentration of MDI: 0.3%). Horizontal lines represent the means. Guinea pigs of the 135 mg/m 3 group were sensitized with monomeric MDI. In all remaining groups polymeric MDI was used.
lobus dexter mediatus, and lobus dexter caudalis of the lung were observed, all five locations were merged into one. As illustrated in Figure 5 , a characteristic influx of eosinophils in the bronchial submucosa and muscularis mucosae existed in MDI-sensitized guinea pigs. There was an apparent shift towards a more pronounced influx in groups induced with the large MDI aerosol.
Following challenge with the small aerosol, the histopathological examination revealed that the id-sensitized animals and those sensitized with a small or large aerosol of MDI experi- enced an almost identical influx of eosinophilic granulocytes at the level of the muscularis mucosae and submucosa. This influx was most pronounced in LALN when induction was by id injection and almost absent when induction was by inhalation. The reverse was observed for the perivascular location, where the small aerosol used for induction was less potent as compared to the large size aerosol. In either case, this difference in response could only be ascertained when challenge was with the small aerosol.
Thus, in relation to animals sensitized by inhalation induction to a large size aerosol, it appears that a greater influx of eosinophilic granulocytes was produced than a similar induction regimen using a small aerosol (Fig. 6, Table 2 ). Overall, for the elicitation of respiratory hypersensitivity, as characterized by an increased influx of eosinophilic granulocytes into the mucosa and submucosa of the airways, a more clear tendency of pronounced response was observed when challenge exposure was with the small rather than the large size aerosol. In either case, however, this response was statistically significantly different from the response seen in the control.
DISCUSSION
In this study, groups of guinea pigs were induced by repeated id injections (cumulative dose Ϸ 0.9 mg MDI/animal) or by single high-level inhalation exposure to 135 mg MDI/m 3 . The calculated total exposure dose was assumed to be Ϸ 0.7 mg MDI/animal (measured respiratory minute volume Ϸ 0.35 L ϫ min -1 per animal; total deposited dose Ϸ 0.35 L ϫ min -1 ϫ 15 min ϫ 0.135 mg MDI ϫ L -1 Ϸ 0.7 mg MDI/ animal). Taking into account the deposition data published by Martonen and Yang (1994) , the small aerosol actually deposited was assumed to be one third; that of the large aerosol was assumed to be two-thirds of the total exposure dose. Based on data from the pilot study, both induction regimens may cause production of MDI-specific IgG 1 antibody and the intensity of response corresponds with the dosimetric calculations made above. In this context, the role of IgG 1 production in guinea pigs is conflicting, because high levels of IgG 1 were apparently associated with lower airway responses to allergen challenge. Importantly, it seems that the amount of IgG 1 antibodies in the guinea pig reflects the exposure dose to the allergen used for induction, but does not relate to the airway responses after allergen challenge. Moreover, a reversely dose-dependent bronchoconstrictive response has been described to occur in guinea pigs (Arakawa et al., 1995; Hayes et al., 1990 Hayes et al., , 1992a Hayes et al., ,b,c, 1995 Pauluhn, 1994a; Pauluhn et al., 1999a) , which is consistent with findings in humans. Lushniak et al. (1998) demonstrated in MDI-exposed individuals that serum concentrations of MDI-specific IgG appear to be a moderately sensitive biological marker of MDI exposure, but not an indicator of occupational asthma. This appears to be consistent with findings in this study. In spite of a mean IgG 1 ratio of approximately 1:20 in guinea pigs sensitized by repeated id injections and by single inhalation exposure to 135 mg MDI/m 3 , the apparent extent of influx of eosinophils into the bronchial airways was almost similar.
Although of different magnitude, in all MDI-sensitized groups the degree of influx of eosinophils in the muscularis mucosae and submucosa was clearly different from similarly challenged, naive controls. The most pronounced difference in response to the small-size and large(r)-size challenge aerosol was observed in the LALN of id-sensitized guinea pigs. When challenge was with the small MDI aerosol, most animals displayed an influx of eosinophils. On the other hand, when challenge was with the large aerosol of MDI, no response was observed. Intradermal induction appears to favor an influx of eosinophils in LALN, whereas induction by the inhalation route (large aerosol) promotes an influx at the perivascular location of the bronchi. The overall scoring of results obtained by measurement of respiratory rate during or following MDI challenge and the examination of influx of eosinophilic granulocytes into the bronchial airways and LALN are summarized in Table 2 . From this comparison it appears that guinea pigs, when challenged with the small aerosol, tended to display a greater respiratory response as well as a more consistent influx of eosinophils within the muscularis mucosae, perivascular area, and LALN than animals challenged with the large aerosol. However, responses at the submucosal location were indistinguishable. Thus, the id route of induction and the single high-level inhalation induction regimen using the large aerosol appeared to demonstrate a greater sensitization efficiency than the single high-level inhalation induction regimen using the small aerosol. Though speculative, this may be related to the greater deposition efficiency of large particles and, accordingly, a greater total deposited dose within the respiratory tract than a preferential deposition at any specific region within the respiratory tract. Moreover, the influx of eosinophils at the perivascular location and LALN appears to depend significantly on the route of induction. Overall, it may be concluded that challenge exposures with this type of irritant aerosol appear to evoke more consistent effects when the MMAD is in the range of Ϸ 2 rather than Ϸ 5 m. For inhalation induction exposures, exposure intensity (and accordingly, exposure dose) may be more important than particle size.
Likewise, combined experimental evidence suggests that in the guinea pig respiratory allergy model, MDI appears to evoke a late-phase rather than any vigorous immediate-onset response as is observed under similar conditions with TMA (Pauluhn et al., 1999a) . This interpretation of findings appears to be supported by other authors using this animal model (Karol and Thorne, 1988) . Using an aerosol of MDI, only late-onset responses were obtained. In contrast, inhalation challenge with an MDI-protein conjugate yielded both type of responses.
In summary, with respect to the inhalation challenge to irritant concentrations, guinea pigs appear to respond differently when challenged with small and large aerosols of the pulmonary irritant MDI. It appears that changes in breathing patterns are more likely to be misconstrued as a positive change of breathing pattern when challenge is made with a large rather than small aerosol, ostensibly due to upper respiratory tract irritation. Especially for agents likely to evoke a late-onset response, the analysis of influx of eosinophils into bronchial airways is considered to be an important adjunct to respiratory function measurements, which commonly focus on respiratory responses occurring during or shortly after challenge exposures. Furthermore, findings appear to demonstrate that particle size is an important variable in inhalation sensitization studies with irritant aerosols, which potentially contributes to interlaboratory variability. However, these data suggest that for the induction of respiratory allergy, the magnitude of the exposure used for induction is apparently more important than particle size, whereas for elicitation of sensitization response more consistent effects were obtained when challenge exposures were made with a small-size aerosol (MMAD Ϸ 2). 
